Pharma & Healthcare

Pharma and Healthcare Market Research Reports

Pharma & Healthcare Market Research Reports, Analysis & Trends

Sub-Categories

Publication Single User License (PDF) Price
Botswana Pharmaceuticals and Healthcare Report Q4 2015

Botswana Pharmaceuticals and Healthcare Report Q4 2015

Date Published: Sep 2 2015

BMI View: Communicable diseases will continue to dominate Botswana's disease profile, with HIV/AIDS
posing the greatest burden. The government's provision of free antiretroviral treatment will provide
opportunities for generic drugmakers within the public healthcare sector. As the economy develops, the
burden of non-communicable diseases will increase, providing a more attractive epidemiological profile for
multinational drugmakers.
Headline Expenditure Projections

$1,295.00
Brazil Pharmaceuticals and Healthcare Report Q4 2015

Brazil Pharmaceuticals and Healthcare Report Q4 2015

Date Published: Sep 2 2015

BMI View: Continued focus on foreign investment along with the expansion of telemedicine and
governmental action to improve medical access will keep Brazil and appealing destination for drugmakers
and healthcare companies in coming years, particularly as the healthcare market remains an outperformer
in the country . This appeal, however, will remain limited in the short to medium term as Brazil's troubled
economy begins to negatively impact other industries including the healthcare and pharmaceutical industry

$1,295.00
Estonia Pharmaceuticals and Healthcare Report Q4 2015

Estonia Pharmaceuticals and Healthcare Report Q4 2015

Date Published: Sep 2 2015

BMI View: We expect growth in Estonia's healthcare expenditure to decelerate over the long term given the
country's fiscally conservative nature, the limited capacity of the national health insurer to accommodate
further healthcare spending growth and BMI's outlook for the country's economy over the long term.
Drugmakers can expect to see constrained revenue growth in the country as pricing pressures and restrictive
drug reimbursement will be employed by the Estonian health insurance fund to restrict healthcare
expenditure.

$1,295.00
Philippines Pharmaceuticals and Healthcare Report Q4 2015

Philippines Pharmaceuticals and Healthcare Report Q4 2015

Date Published: Sep 2 2015

BMI View: The proposed 2016 government budget will be positive for the Philippines healthcare sector.
The budget proposes a significant increase in funds allocated to the Department of Health which will
enable authorities to finance the expansion of the country's health insurance scheme and upgrade medical
facilities in the country. These two thrusts collectively address some of the key impediments to healthcare
access in the Philippines and will reinforce commercial opportunities for pharmaceutical companies

$1,295.00
Ukraine Pharmaceuticals and Healthcare Report Q4 2015

Ukraine Pharmaceuticals and Healthcare Report Q4 2015

Date Published: Sep 2 2015

BMI View: Ukraine's pharmaceutical market will continue to experience inflationary dynamics in 2015, as
the impact of the country's economic instability and the Ukrainian hryvnia's depreciation contribute to drug
price inflation. We expect market share will further shift towards domestic pharmaceutical companies as
the price of imported medicines makes them increasingly unaffordable to consumers. As a result, Ukraine's
attractiveness to multinational drugmakers will decline significantly in the short-term.

$1,295.00
United Kingdom Pharmaceuticals and Healthcare Report Q4 2015

United Kingdom Pharmaceuticals and Healthcare Report Q4 2015

Date Published: Sep 2 2015

BMI View: As a global major powerhouse in R&D and manufacturing of medicines and biotechnology, the
UK will continue to present room for strong sector development, which will be further supported by the last
financial year increase of foreign direct investment in the UK as well as a sustained economic growth
trajectory. This is illustrated by an uptick in multinational funding and venture capital deals in the biotech
industry, such as Inmunocore's latest successful private financing round, investments in the life sciences

$1,295.00
Bulgaria Medical Devices Report Q4 2015

Bulgaria Medical Devices Report Q4 2015

Date Published: Sep 2 2015

BMI Industry View: Bulgaria represents one of the smallest medical device markets in the EU, at
USD258.0mn in 2014. Per capita spending is low at USD36, indicating considerable potential for
expansion. Primarily supplied by imports, we expect the US dollar value of the market to rise by a
2014-2019 CAGR of 1.3%.
Headline Industry Forecasts
■ In US dollar terms, market growth will be weaker due to the projected depreciation of the Bulgarian lev
against the dollar in 2015-2016. This will cause the medical device market to fall by 15.6% in 2015,

$1,295.00
Estonia Medical Devices Report Q4 2015

Estonia Medical Devices Report Q4 2015

Date Published: Sep 2 2015

BMI Industry View: We forecast the medical device market to grow by a CAGR of 2.3% between 2014 and
2019, compared with a CAGR of 6.1% for the 2009-2014 period. The small size of the market limits the
scope for the purchase of more expensive items. The medical device market is largely supplied by imports,
principally from Western suppliers. The trade balance has been positive since 2013, due to sizable exports
of patient aids and other medical devices. There is a small domestic production sector but this tends to

$1,295.00
France Medical Devices Report Q4 2015

France Medical Devices Report Q4 2015

Date Published: Sep 2 2015

BMI Industry View: Although France continues to rank among the top five largest medical device markets
in the world, growth rates are modest by global standards with the rising healthcare needs of the aging
population offset by cost containment measures to control spending on medical devices. Nevertheless, we
believe that the bulk of the government's cost containment programme will continue to hit pharmaceutical
companies harder than medical device companies, which will benefit from measures to support public

$1,295.00
Bahrain Pharmaceuticals and Healthcare Report Q4 2015

Bahrain Pharmaceuticals and Healthcare Report Q4 2015

Date Published: Sep 2 2015

BMI View: Bahrain's government will continue in its attempts at containing the rapidly expanding cost of
healthcare. Private sector engagement and increasing generic substitution will continue to be employed,
although government spending on the sector will continue to increase given its importance in social
stability. The uptake of compulsory health insurance and increased government spending will continue to
drive growth within the pharmaceutical market, with drugmakers viewing Bahrain as a small, but attractive
market.

$1,295.00
Wearable Technology in Sports and Fitness, Healthcare, and Clothing: Market Outlook and Forecasts 2015 - 2020

Wearable Technology in Sports and Fitness, Healthcare, and Clothing: Market Outlook and Forecasts 2015 - 2020

Date Published: Aug 27 2015
Sports, Fitness, Healthcare, and Clothing are emerging as key industries for the early market success of wearable technology.  Mind Commerce sees wearables in Sports and Fitness alone reaching $9.4 billion globally by 2020 with a CAGR of 103%.  Wearable devices within these market segments typically represent an accessory that provides the user with information in support of various applications and/or personal services.
$2,995.00
Maternity and Child Care (MCC) Hospitals Market in India 2015 - 2020

Maternity and Child Care (MCC) Hospitals Market in India 2015 - 2020

Date Published: Aug 27 2015
Indian maternity and child care (MCC) hospitals market is expected to grow at a CAGR of 38% by 2020, finds a new research report launched by NOVONOUS.
$2,500.00
Canada Pharmaceuticals and Healthcare Report Q4 2015

Canada Pharmaceuticals and Healthcare Report Q4 2015

Date Published: Aug 26 2015

BMI View: The second largest market in the Americas region, drugmakers operating in Canada will
continue to benefit from high per capita spending on pharmaceuticals and rising public sector procurement
as a result of the country's aging population. As such, in the near-term, drugmakers will continue to
perceive strong rewards within a transparent and politically stable market. However, a high degree of
public sector cost-cutting will, over the longer-term forcast horizon serve to gradually increase the uptake

$1,295.00
Global Artificial Organ Market 2015-2019

Global Artificial Organ Market 2015-2019

Date Published: Aug 26 2015
Report forecast the global artificial organ market to grow at a CAGR of 7.99% over the period 2014-2019.
Global Artificial Organ Market to grow at a CAGR of 7.99% over the period 2014-2019.
 
$2,500.00
Germany Pharmaceuticals and Healthcare Report Q4 2015

Germany Pharmaceuticals and Healthcare Report Q4 2015

Date Published: Aug 26 2015

BMI View: As the German economy observes signs of a tentative long-term rebalancing in which private
consumption will play a more significant role in economic growth, recent improvements in high frequency
indicators have lead us to an upward revision of the pharmaceutical market growth forecast for 2015.
However, the pharmaceutical market growth potential will continue to suffer significant downward pressure
due to a challenging reimbursement and pricing environment, setting a pattern of marginal market
expansion over the next few years.

$1,295.00
Global Cardiac Markers Market 2015-2019

Global Cardiac Markers Market 2015-2019

Date Published: Aug 26 2015
Report forecast the global cardiac markers market to grow at a CAGR of 9.64% during 2014-2019.
Global Cardiac Markers Market to grow at a CAGR of 9.64% during 2014-2019.
 
$2,500.00
Jordan Pharmaceuticals and Healthcare Report Q4 2015

Jordan Pharmaceuticals and Healthcare Report Q4 2015

Date Published: Aug 26 2015

BMI View: The majority of Jordan's pharmaceuticals will remain sourced from abroad despite the
impressive domestic manufacturing industry. Local drugmakers will continue to supply the market with
generic medicines but higher value innovative drugs will continue to be supplied by multinationals.
Significant counterfeit medicine circulation and economic and political instability in neighbouring Syria
will weigh down the domestic pharmaceutical markets appeal to foreign investment.
Headline Expenditure Projections

$1,295.00
Global Cardiovascular Implants Market 2015-2019

Global Cardiovascular Implants Market 2015-2019

Date Published: Aug 26 2015
Report forecast the global cardiovascular implants market to grow at a CAGR of 4.54% over the period 2014-2019. 
Global Cardiovascular Implants Market to grow at a CAGR of 4.54% over the period 2014-2019.
 
$2,500.00
Kazakhstan Pharmaceuticals and Healthcare Report Q4 2015

Kazakhstan Pharmaceuticals and Healthcare Report Q4 2015

Date Published: Aug 26 2015

BMI View: Although pharmaceutical sales grew at a slower pace than we previously forecast in 2014,
Kazakhstan's pharmaceutical market will maintain its rapid local currency growth rate over the long term.
The government will continue to support increased healthcare expenditure in order to bolster popular
support and ensure political stability, and we expect that this will contribute towards growth in
pharmaceutical sales, boosting the country's attractiveness to multinational drugmakers. A key risk to our

$1,295.00
Global Cell-based Assay Market 2015-2019

Global Cell-based Assay Market 2015-2019

Date Published: Aug 26 2015
Report forecast the global cell-based assay market to grow at a CAGR of 11.3% during 2014-2019.
Global Cell-based Assay Market to grow at a CAGR of 11.3% during 2014-2019.
 
$2,500.00

Pages

Shopping cart

0 Items $0.00
Not able to find what you are looking for?
Call Us
WHY CHOOSE MARKET RESEARCH REPORTS?
1
Trusted By Leaders
2
Shop With Confidence
3
Customer Centric
4
Personalized Solutions
5
Secure Checkout

User login

Clients Who Trust Us

Orange, Google, Microsoft, Barclays, CassidianIntel, TPG, Elit Net, Cross Business Producers, AcmavolpakP&G, Cisco, Gemalto, General Insurance Corporation of India, Aviva, Cognizant, InoxWindB. Braun, Cobham, fiserv, Harris, Wipro, AonAl Meera, Nomura Research Institute, Tata Consultancy Services, Amara Raja, Hiranandani EnergyMunich Re, Lotte Chemical, National Post, First Data